BeOne Medicines
ONC
#735
Rank
C$47.64 B
Marketcap
C$459.26
Share price
-0.27%
Change (1 day)
13.57%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2026 (TTM): C$6.65

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is C$6.78. In 2025 the company made an earnings per share (EPS) of C$3.85 an increase over its 2024 EPS that were of C-$8.79.

EPS history for BeOne Medicines from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$6.6572.83%
2025C$3.85-143.75%
2024C-$8.79
2022C-$27.4828.21%
2021C-$21.43-19.96%
2020C-$26.7820.81%
2019C-$22.1731.52%
2018C-$16.85417.57%
2017C-$3.26-37.16%
2016C-$5.18158.95%
2015C-$2.00

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
C-$0.38-105.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
C-$1.34-119.75%๐Ÿ‡บ๐Ÿ‡ธ USA